200
Participants
Start Date
August 31, 2002
Primary Completion Date
October 31, 2003
Study Completion Date
December 31, 2007
Follow up from previous treatment with MEDI-507
There will be no investigational drugs administered under this protocol.
Universitaur Ziekenhuis Gent, Ghent
Academisch Medisch Centrum/Universiteit van Amsterdam (AMC/UvA), Amsterdam
CHU Centre Ville, Liège
Atlanta Dermatology, Vein & Research Center, LLC, Alpharetta
VA Medical Center, Nashville
Washington University, Dermatology Clinical Trials Unit, St Louis
Dermatology Research Clinic, Little Rock
Future Care Studies, Springfield
Cherry Creek Dermatology, Denver
Northwest Kinetics, Tacoma
Capital District Health Authority, QE II Health Sciences Center, Halifax
International Dermatology Research, Montreal
Innovaderm Research, Montreal
Hotel Dieu/Clinque Dermatologique, Nantes
Hospital Saint-Louis Service de Dermatologie 1, Paris
Hospital Haut Leveque CHU Sud -Service de Dermatologie, Pessac
Universitataskilinkum der TU Dresden, Dresden
Universitatsklinikum Hautklinik, Düsseldorf
Klinikum de Johann - Wolfgang Goethe Universitate Frankfurt, Frankfurt
St. Urban, Dermatologie, Freiburg im Breisgau
Universitatsklinikum Hautklinik, Tübingen
Lead Sponsor
MedImmune LLC
INDUSTRY